These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17611307)

  • 1. Genetic testing to identify high-risk populations for chemoprevention studies.
    Velasquez JL; Lipkin SM
    Cancer Biomark; 2007; 3(3):163-8. PubMed ID: 17611307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What are SNPs and haplotypes and how will they help us manage the prevention of adult cancer?
    Velasquez JL; Lipkin SM
    Curr Oncol Rep; 2005 Nov; 7(6):475-9. PubMed ID: 16221385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
    Greenwald P
    J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct-to-consumer genetic tests: flawed and unethical.
    Lancet Oncol; 2008 Dec; 9(12):1113. PubMed ID: 19038754
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical genotyping: the need for interrogation of single nucleotide polymorphisms and mutations in the clinical laboratory.
    Tsongalis GJ; Coleman WB
    Clin Chim Acta; 2006 Jan; 363(1-2):127-37. PubMed ID: 16102741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scanning the horizon: what is the future of genome-wide association studies in accelerating discoveries in cancer etiology and prevention?
    Hunter DJ; Thomas G; Hoover RN; Chanock SJ
    Cancer Causes Control; 2007 Jun; 18(5):479-84. PubMed ID: 17440825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk biomarkers and current strategies for cancer chemoprevention.
    Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC
    J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [How about the uncertainty in the haplotypes in the population-based KORA studies?].
    Heid IM; Lamina C; Bongardt F; Fischer G; Klopp N; Huth C; Küchenhoff H; Kronenberg F; Wichmann HE; Illig T
    Gesundheitswesen; 2005 Aug; 67 Suppl 1():S132-6. PubMed ID: 16032531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The promise of genetically engineered mice for cancer prevention studies.
    Green JE; Hudson T
    Nat Rev Cancer; 2005 Mar; 5(3):184-98. PubMed ID: 15738982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multigene panel testing versus syndrome-specific germline testing for inherited cancer risk: 'a somewhat different way'.
    Biller LH; Yurgelun MB
    Per Med; 2019 Mar; 16(2):83-86. PubMed ID: 30741585
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid genetic screening for major human leukocyte antigen risk haplotypes in patients with type 1 diabetes from Northeastern Brazil.
    Brandao LC; Vatta S; Guimaraes R; Segat L; Araujo J; De Lima Filho JL; Arraes LC; Not T; Crovella S
    Hum Immunol; 2010 Mar; 71(3):277-80. PubMed ID: 20035815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the molecular genetics of epilepsy.
    Hildebrand MS; Dahl HH; Damiano JA; Smith RJ; Scheffer IE; Berkovic SF
    J Med Genet; 2013 May; 50(5):271-9. PubMed ID: 23468209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The genetic revolution-impact on therapy and prevention].
    Propping P; Aretz S
    Internist (Berl); 2004 Jun; 45 Suppl 1():S6-14. PubMed ID: 15241503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer.
    Bernig T; Chanock SJ
    Expert Rev Mol Diagn; 2006 May; 6(3):319-31. PubMed ID: 16706736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutrition and cancer prevention: diet-gene interactions.
    Mathers JC
    Proc Nutr Soc; 2003 Aug; 62(3):605-10. PubMed ID: 14692596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic predisposition testing for cancer: effects on families' lives.
    MacDonald DJ
    Holist Nurs Pract; 1998 Apr; 12(3):9-19. PubMed ID: 9624953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline genetic variants associated with prostate cancer and potential relevance to clinical practice.
    Goh CL; Eeles RA
    Recent Results Cancer Res; 2014; 202():9-26. PubMed ID: 24531773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A review on genetic testing].
    Xie Y; Wu MQ
    Sheng Wu Gong Cheng Xue Bao; 2006 Mar; 22(2):338-43. PubMed ID: 16607966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating mechanistic and polymorphism data to characterize human genetic susceptibility for environmental chemical risk assessment in the 21st century.
    Mortensen HM; Euling SY
    Toxicol Appl Pharmacol; 2013 Sep; 271(3):395-404. PubMed ID: 21291902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of genome-wide association studies, direct-to-consumer genetic testing, and high-speed sequencing technologies on predictive genetic counselling for cancer risk.
    Speicher MR; Geigl JB; Tomlinson IP
    Lancet Oncol; 2010 Sep; 11(9):890-8. PubMed ID: 20537948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.